logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Kabra Drugs Share Price

Kabra Drugs Ltd.

28.49

-0.05(-0.18%)
10th Apr 2026 | 3:28 PM
NSE :
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Kabra Drugs Performance

Price Movement

N/A

₹28.06

₹29.34

Today's LowToday's High

1 Year Performance

Data is not available

Markets Today

High₹29.34
Low₹28.06
Open at₹28.54
Prev Close₹28.54
Volumes48.05 K
Avg Price₹28.36
Lower Circuit₹25.69
Upper Circuit₹31.39

Historical Performance

3M High₹35.52
3M Low₹24.50
1 Yr High₹35.52
1 Yr Low₹10.56
3 Yr High₹35.52
3 Yr Low₹3.18
5 Yr High₹35.52
5 Yr Low₹2.95

Kabra Drugs Fundamentals

Market Cap
Below industry Median
67.10 Cr.
PE Ratio (TTM)
Below industry Median
15.60
Dividend Yield
0
Net Profit TTM
332.4% incr over last year
4.30
Net Profit Growth
332.4% incr over last year
4.30
PEG Ratio
Below industry Median
0
ROE
-4.40
Operating Revenue TTM
57.33
Operating Revenue Growth
-
Book Value
Below industry Median
2.30
MFI
MFI is mid-range
32.18
RSI
RSI is mid-range
51.38
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
2.30

Kabra Drugs Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue30.4219.767.1500
Operating Expense27.9917.737.660.240.53
Operating Profit2.432.04-0.51-0.24-0.53
Depreciation0.010.0100.010
Interest00000
Tax0.400.37000
Net Profit2.571.84-0.500.39-0.54

Kabra Drugs Technicals

Kabra Drugs Ltd. EMA & SMA

28.49

-0.05 (-0.18%)

Bullish Moving Average

12

Bearish Moving Average

4

Day EMA5 ₹27.9
Day EMA10 ₹27.5
Day EMA12 ₹27.5
Day EMA20 ₹27.8
Day EMA26 ₹28
Day EMA50 ₹28.5
Day EMA100 ₹27.4
Day EMA200 ₹23.6

Kabra Drugs Support and Resistance

Resistance

First Resistance₹29.07
Second Resistance₹29.84
Third Resistance₹30.35

Support

First Support₹27.79
Second Support₹27.28
Third Support₹26.51

Technical Indicators

Day RSI51.38
Day MFI32.18
Day ADX21.68
Day Commodity Channel Index53.60
William-23.43
Day MACD-0.54
Day MACD Signal Line-0.87
Day ATR1.63
Day ROC12567.20
Day ROC21-5.42

Kabra Drugs Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter000000
FII000000
DII000000
Public100100100100100100

Kabra Drugs Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day31.39 K38.03 K82.54%
Week48.95 K56.04 K87.35%
1 Month53.41 K62.68 K85.22%
6 Month1.35 L1.55 L87.12%

Kabra Drugs SWOT Analysis

Strengths14
Weakness4
Opportunity0
Threats0

Turnaround Potential (DVM)

Undervalued Growth Stocks

Consistent high performing stocks over Five Years

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Kabra Drugs Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
No Record Found

Kabra Drugs Stock Comparison

Financials
Price (₹)₹424.60₹155.30₹203₹39.87₹7.36₹362.10
% Change0.45%4.97%0.42%2.00%4.99%2.00%
Revenue TTM (₹ Cr)---₹0.54₹83.60-
Net Profit TTM (₹ Cr)---₹-0.24₹-34.95-
PE TTM-15.9055.70-101.40-1.7080.10
1 Year Return8.15786636
ROCE28.91----5.63-

FAQ's on KABRADG

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy